Big alert: As per market grapevine, companies are increasingly raising equity instead of bank funding, shifting greater business risk to investors. With many SME stocks still trading at stretched valuations, avoid junk SME IPOs and check valuations and future prospects before applying.

Friday night closing: Crude closed at $103.87, Dow fell 95 points, Nasdaq rose 104 points and S&P 12 points, while Gift Nifty fell 61 points to 23,300, signalling a possible gap-down opening on Monday, subject to weekend developments. Brent crude above $80 remains a major negative for the Indian economy.

Chemcon Speciality Chemicals has Rs.447 cr. reserves and 74.47% promoter holding. Q1FY27 PAT rose 72% to Rs.11 cr. New organic chemicals, product expansion and cost efficiencies support FY27 growth. At Rs.192, attractive versus 52-week high of Rs.295. AGM on 17-9-2026.

Morepenlab reported record Q1 FY27 performance with EBITDA/PAT growth of 207%/394%, supported by API recovery, exports, CDMO and Medical Devices. Stock looks attractive at CMP versus its lifetime high of Rs.222.

Chemcon Speciality Chemicals reported a strong start to FY27, supported by better realisations, newer products and customer traction. Stock looks attractive at CMP versus its all-time high of Rs.731. AGM on 17th September 2026.

Stock picking alone doesn’t create wealth. Allocation, conviction and risk management are equally important. Allocate 60-70% to 5-7 high-conviction stocks and keep 30-40% for opportunities, momentum calls and active circulation.

Don’t chase fast wealth: Want to get rich quickly? Remember, the market can take your money just as quickly. Fast wealth has two speeds — going up and coming down, with the second often having no brakes! Patience may be boring, but being broke is worse. If someone promises to double your money in days, ask why they are telling you instead of doing it themselves…….

As per market grapevine, markets may remain highly volatile with a sell-on-rise approach due to high crude, inflation, AI impact, weak monsoon, heavy IPO pipeline and continued supply through block/bulk deals, OFS and QIPs. Focus only on selected growth stocks with strong Q1 EBITDA/PAT, optimistic Q2FY27 outlook and attractive valuations. Atlantaele, Ambicaagar, Arrowgreen, Blackrose, Chemcon, Haldyngl, IOLCP, Jyoti, Morepenlab, Princepipe and Sukhjits may give good returns in the next 2-3 months. Keep on radar.

Nifty 50 annual returns were +3.0% in 2016, +28.6% in 2017, +3.2% in 2018, +12.0% in 2019, +14.9% in 2020, +24.1% in 2021, +4.3% in 2022, +20.0% in 2023, +8.8% in 2024, +10.5% in 2025 and -9.9% in 2026 YTD.

Chemcon Speciality Chemicals reported a strong FY27 start, driven by better realisations, new products and customer traction. Attractive versus its Rs.731 lifetime high.